Abstract
Possible involvement of dopaminergic (DAergic) system in forced swimming-induced immobility (despair behaviour) was investigated in mice. B-HT 920 (0.05 and 0.1 mg/kg), a post-synaptic DAergic agonist, produced a dose dependent reduction in immobility period, which was sensitive to blockade by haloperidol (0.5 mg/kg) and sulpiride (100 mg/kg). This effect was also blocked by α 2 antagonist yohimbine (5 mg/kg). SKF 38393 (5 mg/kg), a D 1-DA agonist potentiated the action of B-HT 920. Reserpinization (2 mg/kg, 24 hr prior) produced despair immobility in mice. When a low dose of B-HT 920 (0.05 mg/kg) was given to reserpinized animals, the duration of immobility period was further increased. But on the other hand, a higher dose (0.1 mg/kg) of it reduced reserpine-induced immobility. Desipramine (5 and 10 mg/kg), elicited a dose dependent reduction in the immobility period, which was sensitive to blockade by sulpiride (100 mg/kg). Desipramine (10 mg/kg) showed a biphasic response in combination with B-HT 920, i.e., a potentiation of the response due to a low dose of B-HT 920 (0.05 mg/kg) and an antagonism of the response due to a higher dose of B-HT 920 (0.1 mg/kg), respectively. SKF 38393 (5 mg/kg), potentiated the action of desipramine (5 mg/kg). SKF 38393 (5 mg/kg) further potentiated the action of desipramine (5 mg/kg) and B-HT 920 (0.05 mg/kg). These observations suggests that B-HT 920 reduces behavioural immobility by DAergic mechanism and desipramine also modulates D 2-DA receptors in its anti-depressant action.
Original language | American English |
---|---|
Journal | Indian journal of experimental biology |
Volume | 32 |
State | Published - Jan 1 1994 |
Keywords
- 2
- 3
- 4
- 5 tetrahydro 7
- 8 dihydroxy 1 phenyl 1h 3 benzazepine
- Animal
- Antidepressive Agents
- Azepines
- Dopamine
- Drug Interactions
- Escape Reaction
- Mice
- Motor Activity
- Receptors
- SKF-38393
- Swimming
- animal experiment
- animal model
- article
- controlled study
- desipramine
- dopamine receptor
- dopamine receptor blocking agent
- dopamine receptor stimulating agent
- female
- haloperidol
- immobilization
- male
- mouse
- nonhuman
- reserpine
- sulpiride
- talipexole
- yohimbine
Disciplines
- Life Sciences